The Registry of Toxic Effects of Chemical Substances
Cobalt (II) chloride |
UPDATE: May 2005 | MW: 129.83 | MF: Cl2Co |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
skin | human
1%/48 hour
|
|
CODEDG 12,93,1985
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
DNA damage
|
mammal (species unspecified)
lymphocyte
|
750 µmol/L
|
SCIEAS 198,513,1977
|
DNA damage
|
other microorganisms
|
750 µmol/L
|
SCIEAS 198,513,1977
|
DNA inhibition
|
human
HeLa cell
|
1 mmol/L
|
MUREAV 92,427,1982
|
DNA repair
|
Bacillus subtilis
|
50 mmol/L
|
MUREAV 77,109,1980
|
unscheduled DNA synthesis
|
hamster
embryo
|
200 µmol/L
|
MUREAV 131,173,1984
|
mutation in microorganisms
|
Salmonella typhimurium
|
1 mg/L (+enzymatic activation step)
|
BECTA6 40,597,1988
|
mutation in microorganisms
|
Saccharomyes cerevisiae
|
100 µmol/L (-enzymatic activation step)
|
CPBTAL 33,1571,1985
|
gene conversion and mitotic recombination
|
Saccharomyes cerevisiae
|
3 gm/L
|
MUREAV 155,117,1985
|
mutation in mammalian somatic cells
|
hamster
lung
|
200 µmol/L
|
MUREAV 68,259,1979
|
specific locus test
|
oral | Drosophila melanogaster
2 mmol/L
|
MUREAV 320,133,1994
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lowest published toxic dose: 25 mg/kg (10 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
JPMSAE 58,766,1969
|
intraperitoneal | rat
lowest published toxic dose: 30 gm/kg (15-16 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
TJADAB 29(3),23A,1984
|
oral | mouse
lowest published toxic dose: 7,280 mg/kg (13 week male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Paternal effects: Testes, epididymis, sperm duct Reproductive: Effects on fertility: Male fertility index (e.g., # males impregnating females per # males exposed to fertile nonpregnant females)
TOXID9 6,31,1986
|
oral | rat
lowest published toxic dose: 11 mg/kg (1-22 day pregnant)
|
Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea)
|
GISAAA 45(2),6,1980
|
subcutaneous | rat
lowest published toxic dose: 77.9 mg/kg (1 day pregnant-2 day after birth)
|
Reproductive: Effects on newborn: Biochemical and metabolic
|
EKFAE9 58,41,1995
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
subcutaneous | rat
lowest published toxic dose: 400 mg/kg/19 day- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Tumorigenic: Tumors at site of application
LBANAX 11,43,1977
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | chicken
lowest published toxic dose: 10 mg/kg
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
|
CBPAB5 46,427,1973
|
intraperitoneal | chicken
lowest published toxic dose: 20 mg/kg
|
Endocrine: Other changes
|
CBPAB5 46,427,1973
|
intraperitoneal | chicken
lowest published toxic dose: 40 mg/kg
|
Endocrine: Hyperglycemia
|
CBPAB5 46,427,1973
|
intraperitoneal | guinea pig
lowest published lethal dose: 165 mg/kg
|
N/R
|
AEHLAU 11,201,1965
|
intraperitoneal | mouse
lethal dose (50 percent kill): 49 mg/kg
|
N/R
|
AEPPAE 244,17,1962
|
intraperitoneal | rat
lethal dose (50 percent kill): 17,402 µg/kg
|
N/R
|
JAPMA8 48,143,1959
|
intraperitoneal | rat
lowest published toxic dose: 2.2 mg/kg
|
Endocrine: Hyperglycemia | Blood: Other changes
TXAPA9 32,316,1975
|
intraperitoneal | rat
lethal dose : 30 mg/kg
|
Cardiac: Cardiomyopathy including infarction | Cardiac: Arrythmias (indlucing changes in conduction) Vascular: Thromobosis distant from injection site
VCVN5* -,455,1989
|
intravenous | dog
lowest published lethal dose: 36 mg/kg
|
N/R
|
HBAMAK 4,1289,1935
|
intravenous | mouse
lethal dose (50 percent kill): 23,300 µg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Convulsions or effect on seizure threshold
INJPD2 23,153,1991
|
intravenous | rat
lethal dose (50 percent kill): 4,300 µg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Convulsions or effect on seizure threshold
INJPD2 23,153,1991
|
intravenous | rabbit
lowest published toxic dose: 20 mg/kg
|
Gastrointestinal: Hypermotility, diarrhea | Gastrointestinal: Changes in structure or function of exocrine pancreas Endocrine: Hyperglycemia
PSEBAA 82,406,1953
|
intravenous | rabbit
lowest published lethal dose: 40 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Lung, Thorax, or Respiration: Dyspnea
PSEBAA 82,406,1953
|
intravenous | rabbit
lowest published lethal dose: 9 mg/kg
|
Behavioral: Food intake (animal) | Behavioral: Muscle contraction or spasticity Kidney, Ureter, and Bladder: Incontinence
VCVN5* -,453,1989
|
intravenous | rabbit
lowest published toxic dose: 10 mg/kg
|
Vascular: BP lowering not characterized in autonomic section | Endocrine: Hyperglycemia
VCVN5* -,454,1989
|
intravenous | rabbit
lowest published toxic dose: 0.1 mg/kg
|
Peripheral Nerve and Sensation: Recording from peripheral motor nerve
|
VCVN5* -,454,1989
|
oral | child
lowest published toxic dose: 48 mg/kg
|
Behavioral: Anorexia (human) | Endocrine: Thyroid weight (goiter) Nutritional and Gross Metabolic: Weight loss or decreased weight gain
JAMAAP 157,117,1955
|
oral | child
lowest published lethal dose: 1,500 mg/kg
|
N/R
|
34ZIAG -,182,1969
|
oral | guinea pig
lethal dose (50 percent kill): 55 mg/kg
|
N/R
|
VCVN5* -,453,1989
|
oral | man
lowest published toxic dose: 1,042 mg/kg/13 week- intermittent
|
Eye: Optic nerve neuropathy | Eye: Visual field changes
IJMDAI 8,61,1972
|
oral | mouse
lethal dose (50 percent kill): 80 mg/kg
|
N/R
|
VCVN5* -,453,1989
|
oral | rat
lethal dose (50 percent kill): 80 mg/kg
|
N/R
|
HYSAAV 36(1-3),277,1971
|
oral | rat
lethal dose (50 percent kill): 418 mg/kg
|
Kidney, Ureter, and Bladder: Changes in both tubules and glomeruli | Blood: Hemorrhage
VCVN5* -,453,1989
|
oral | rabbit
lowest published lethal dose: 1,272 mg/kg
|
N/R
|
SMSJAR 26,131,1826
|
oral | rabbit
lowest published toxic dose: 0.1 mg/kg
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
VCVN5* -,454,1989
|
subcutaneous | mouse
lowest published toxic dose: 60 mg/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
TOLED5 138,235,2003
|
subcutaneous | rat
lowest published toxic dose: 32.458 mg/kg
|
Lung, Thorax, or Respiration: Respiratory depression | Blood: Changes in erythrocyte (RBC) count
VCVN5* -,454,1989
|
subcutaneous | rabbit
lowest published lethal dose: 200 mg/kg
|
N/R
|
HBAMAK 4,1289,1935
|
skin | guinea pig
lowest published lethal dose: 165 mg/kg
|
N/R
|
AEHLAU 11,201,1965
|
skin | rat
lowest published lethal dose: 2 gm/kg
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
RCCRC* NOTOX1073/1335,1988
|
unreported route | rat
lowest published toxic dose: 10 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
|
VCVN5* -,455,1989
|
unreported route | rabbit
lowest published toxic dose: 0.2 mg/kg
|
Vascular: BP lowering not characterized in autonomic section
|
VCVN5* -,456,1989
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rabbit
lowest published toxic concentration: 0.5 mg/m3/6 hour/4 week- intermittent
|
Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi | Lung, Thorax, or Respiration: Emphysema Immunological Including Allergic: Decreased immune response
VCVN5* -,457,1989
|
intraperitoneal | guinea pig
lowest published toxic dose: 60 mg/kg/2 day- intermittent
|
Kidney, Ureter, and Bladder: Proteinuria | Endocrine: Hyperglycemia
VCVN5* -,459,1989
|
intraperitoneal | guinea pig
lowest published toxic dose: 180 mg/kg/6 day- intermittent
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) | Kidney, Ureter, and Bladder: Urine volume decreased or anuria
VCVN5* -,459,1989
|
intravenous | dog
lowest published toxic dose: 1,150 mg/kg/10 week- intermittent
|
Behavioral: Somnolence (general depressed activity) | Cardiac: Other changes Lung, Thorax, or Respiration: Dyspnea
TXAPA9 61,89,1981
|
oral | man
lowest published toxic dose: 220 µg/kg/22 day- intermittent
|
Blood: Changes in erythrocyte (RBC) count
|
TOXID9 72,246,2003
|
oral | rat
lowest published toxic dose: 1,003 mg/kg/30 week- intermittent
|
Behavioral: Alteration of classical conditioning
|
GISAAA 36(2),95,1971
|
oral | rat
lowest published toxic dose: 140 mg/kg/2 week- intermittent
|
Cardiac: Other changes
|
VCVN5* -,459,1989
|
oral | rat
lowest published toxic dose: 90 mg/kg/30 week- intermittent
|
Behavioral: Alteration of classical conditioning | Blood: Changes in erythrocyte (RBC) count Immunological Including Allergic: Decrease in cellular immune response
VCVN5* -,462,1989
|
oral | rabbit
lowest published toxic dose: 140 mg/kg/2 week- intermittent
|
Cardiac: Other changes
|
VCVN5* -,459,1989
|
subcutaneous | rat
lowest published toxic dose: 60 mg/kg/3 day- intermittent
|
Behavioral: Food intake (animal) | Liver: Changes in liver weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain
JJPAAZ 43,335,1987
|
subcutaneous | rat
lowest published toxic dose: 77.9 mg/kg/24 day- intermittent
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
EKFAE9 58,41,1995
|
subcutaneous | rat
lowest published toxic dose: 46 mg/kg/2 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
FCTOD7 41,431,2003
|
unreported route | dog
lowest published toxic dose: 2 mg/kg/10 day- intermittent
|
Gastrointestinal: Alteration in gastric secretion
|
VCVN5* -,462,1989
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Limited Evidence
|
IMEMDT 52,363,1991
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 52,363,1991
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 2B
|
IMEMDT 52,363,1991
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,227,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,109,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,151,2004
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - UNITED KINGDOM
|
Carcinogen, SEP2000
|
|
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 84329; | Number of Industries 13; Total Number of Facilities 267; Number of Occupations 12; Total Number of Employees Exposed 2,790
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 84329; |
Number of Industries 9; Total Number of Facilities 185; Number of Occupations 13; Total Number of Employees Exposed 9,392; Total Number of Female Employees Exposed 4,192 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Positive: B subtilis rec assay; S cerevisiae-homozygosis
|
EPA GENETOX PROGRAM 1988, Negative: N crassa-aneuploidy
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as absorbent for AMMONIA, gas masks, electroplating, sympathetic inks, hygrometers
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
|
REFERENCES:
CODEN
|
|
REFERENCE
34ZIAG
|
"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969
|
AEHLAU
|
Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC
20016) V.1- 1960-
|
AEPPAE
|
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.)
V.110-253, 1925-66. For publisher information, see NSAPCC.
|
BECTA6
|
Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc.,
Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966-
|
CBPAB5
|
Comparative Biochemistry and Physiology, A: Comparative Physiology. (Elsevier Science, 660
White Plains Rd., Tarrytown, NY 10591) V.30- 1971-
|
CODEDG
|
Contact Dermatitis. Environmental and Occupational Dermatitis. (Munksgaard International
Pub., c/o Publications Expediting Inc., 200 Meacham Ave., Elmont, NY 11003) V.1- 1975-
|
CPBTAL
|
Chemical and Pharmaceutical Bulletin. (Japan Pub. Trading Co., USA, 1255 Howard St., San
Francisco, CA 94103) V.6- 1958-
|
EKFAE9
|
Eksperimental'naya i Klinicheskaya Farmakologiya. Experimental and Clinical Pharmacology.
(Mezhdunarodnaya Kniga, ul. B. Yakimanka, 39, 117049 Moscow, Russia) V.55- 1992-
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
HBAMAK
|
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.)
|
HYSAAV
|
Hygiene and Sanitation (USSR). English translation of GISAAA. (Springfield, VA) 1964-71.
Discontinued.
|
IJMDAI
|
Israel Journal of Medical Sciences. (POB 1435, Jerusalem 91013, Israel) V.1- 1965-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
INJPD2
|
Indian Journal of Pharmacology. (Dept. of Pharmacology, Baranas Hindu Univ., Varanasi 221
005, India) V.1- 1968(?)-
|
JAMAAP
|
JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL
60610) V.1- 1883-
|
JAPMA8
|
Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC)
V.29-49, 1940-60. For publisher information, see JPMSAE.
|
JJPAAZ
|
Japanese Journal of Pharmacology. (Japanese Pharmacological Soc., c/o Dept. of Pharmacology,
Faculty of Medicine, Kyoto Univ., Sakyo-ku, Kyoto 606, Japan) V.1- 1951-
|
JPMSAE
|
Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave.,
NW, Washington, DC 20037) V.50- 1961-
|
LBANAX
|
Laboratory Animals. (Laboratory Animals Ltd., 1 Thrifts Mead, Theydon Bois, Essex CM16 7NF,
UK) V.1- 1967-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
PSEBAA
|
Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1903/04-
|
RCCRC*
|
Research and Consulting Company, Technical Reports. (RCC NOTOX B.V., Hambakenwetering 7, 5231
DD 's-Hertogenbosch, Netherlands)
|
SCIEAS
|
Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC
20005) V.1- 1895-
|
SMSJAR
|
Scottish Medical and Surgical Journal. (Edinburgh, Scotland) For publisher information, see
SMDJAK.
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
VCVN5*
|
"Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous
substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al.,
Chimia, 1989.
|
|